1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Artificial Pancreas Device Systems Market
2.2. Global Artificial Pancreas Device Systems Market, By Device Type, 2023 (US$ Million)
2.3. Global Artificial Pancreas Device Systems Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Artificial Pancreas Device Systems Market: Competitive Analysis
3.1. Market Positioning of Key Artificial Pancreas Device Systems Market Vendors
3.2. Strategies Adopted by Artificial Pancreas Device Systems Market Vendors
3.3. Key Industry Strategies
4. Artificial Pancreas Device Systems Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Artificial Pancreas Device Systems Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Threshold Suspend Device System
5.3.2. Control-to-Range (CTR) Systems
5.3.3. Control-to-Target (CTT) Systems


6. North America Artificial Pancreas Device Systems Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
6.3.Artificial Pancreas Device Systems Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)

7. UK and European Union Artificial Pancreas Device Systems Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
7.3.Artificial Pancreas Device Systems Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)

8. Asia Pacific Artificial Pancreas Device Systems Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
8.3.Artificial Pancreas Device Systems Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)

9. Latin America Artificial Pancreas Device Systems Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
9.3.Artificial Pancreas Device Systems Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)

10. Middle East and Africa Artificial Pancreas Device Systems Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
10.3.Artificial Pancreas Device Systems Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Artificial Pancreas Device Systems Market: By Device Type, 2022-2032, USD (Million)

11. Company Profile
11.1. Medtronic, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Johnson & Johnson
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Pancreum LLC
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Tandem Diabetes Care, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. JDRF
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives